Letter: Crisis In The Community

All of us are clearly aware that the funding levels for some institutes of NIH have been failing, some precipitously so, over the last several years. However, the most recent actions (fiscal 1990) that have further reduced funding levels brings the scientific community to the edge of a present, and future, catastrophe. The Bush administration says we have a crisis in science education; the crisis is in our ability to conduct science itself. There are many bright, talented young investigators wh

Written byDuane Haines
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

All of us are clearly aware that the funding levels for some institutes of NIH have been failing, some precipitously so, over the last several years. However, the most recent actions (fiscal 1990) that have further reduced funding levels brings the scientific community to the edge of a present, and future, catastrophe. The Bush administration says we have a crisis in science education; the crisis is in our ability to conduct science itself.

There are many bright, talented young investigators who are sitting on, for example, approved grant applications at the 13th or 14th percentile that will not be funded because funding levels in some institutes will now not go above the 11th to 12th percentile. Inevitably these individuals are beginning to ask themselves how are they going to have a research career if they do not have the opportunity to get one started. It is well known that some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies